LT97116A - Erythromycin a 9-o-oxime derivatives endowed with antibiotic activity - Google Patents

Erythromycin a 9-o-oxime derivatives endowed with antibiotic activity

Info

Publication number
LT97116A
LT97116A LT97-116A LT97116A LT97116A LT 97116 A LT97116 A LT 97116A LT 97116 A LT97116 A LT 97116A LT 97116 A LT97116 A LT 97116A
Authority
LT
Lithuania
Prior art keywords
erythromycin
antibiotic activity
oxime derivatives
derivatives endowed
endowed
Prior art date
Application number
LT97-116A
Other versions
LT4276B (en
Inventor
Franco Pellacini
Giovanna Schioppacassi
Enrico Albini
Daniela Botta
Stefano Romagnano
Francesco Santangelo
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Publication of LT97116A publication Critical patent/LT97116A/en
Publication of LT4276B publication Critical patent/LT4276B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
LT97-116A 1994-12-13 1997-07-07 Erythromycin a 9-o-oxime derivatives endowed with antibiotic activity LT4276B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT94MI002496A IT1276901B1 (en) 1994-12-13 1994-12-13 DERIVATIVES OF Erythromycin A 9-0-OXIN WITH ANTIBIOTIC ACTIVITY

Publications (2)

Publication Number Publication Date
LT97116A true LT97116A (en) 1997-10-27
LT4276B LT4276B (en) 1998-01-26

Family

ID=11369979

Family Applications (1)

Application Number Title Priority Date Filing Date
LT97-116A LT4276B (en) 1994-12-13 1997-07-07 Erythromycin a 9-o-oxime derivatives endowed with antibiotic activity

Country Status (35)

Country Link
US (1) US5847092A (en)
EP (1) EP0797579B1 (en)
JP (1) JPH10510520A (en)
KR (1) KR100367559B1 (en)
CN (1) CN1046535C (en)
AP (1) AP739A (en)
AT (1) ATE190620T1 (en)
AU (1) AU690791B2 (en)
BG (1) BG63261B1 (en)
BR (1) BR9510015A (en)
CA (1) CA2207029A1 (en)
CZ (1) CZ289943B6 (en)
DE (1) DE69515694T2 (en)
DK (1) DK0797579T3 (en)
EE (1) EE03401B1 (en)
ES (1) ES2144154T3 (en)
FI (1) FI972493A (en)
GE (1) GEP20012391B (en)
GR (1) GR3033622T3 (en)
HU (1) HU220631B1 (en)
IT (1) IT1276901B1 (en)
LT (1) LT4276B (en)
LV (1) LV11898B (en)
MD (1) MD1788G2 (en)
NO (1) NO309816B1 (en)
NZ (1) NZ297446A (en)
OA (1) OA10491A (en)
PL (1) PL182053B1 (en)
PT (1) PT797579E (en)
RO (1) RO116282B1 (en)
RU (1) RU2152951C1 (en)
SI (1) SI9520124A (en)
TJ (1) TJ306B (en)
UA (1) UA48958C2 (en)
WO (1) WO1996018633A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1290447B1 (en) * 1997-03-28 1998-12-03 Zambon Spa 1,3-OSSATIOLANIC DERIVATIVES FOR ANTI-VIRAL ACTIVITY
IT1301967B1 (en) * 1998-07-30 2000-07-20 Zambon Spa ERYTHROMYCIN DERIVED FROM ANTIBIOTIC ACTIVITY
IT1301968B1 (en) * 1998-07-30 2000-07-20 Zambon Spa ERYTHROMYCIN DERIVATIVES FOR ANTIBIOTIC ACTIVITY
IT1306205B1 (en) * 1999-01-15 2001-05-30 Zambon Spa MACROLIDS WITH ANTI-INFLAMMATORY ACTIVITY.
US6947844B2 (en) 2000-08-09 2005-09-20 Yale University Modulators of ribosomal function and identification thereof
US6638908B1 (en) 2000-08-09 2003-10-28 Yale University Crystals of the large ribosomal subunit
IL151012A0 (en) 2001-08-03 2003-02-12 Ribosomes Structure And Protei Ribosomes structure and protein synthesis inhibitors
US6952650B2 (en) 2001-08-03 2005-10-04 Yale University Modulators of ribosomal function and identification thereof
ITMI20021726A1 (en) 2002-08-01 2004-02-02 Zambon Spa MACROLIDS WITH ANTI-INFLAMMATORY ACTIVITY.
TW200420573A (en) 2002-09-26 2004-10-16 Rib X Pharmaceuticals Inc Bifunctional heterocyclic compounds and methods of making and using same
JP5383037B2 (en) 2004-02-27 2014-01-08 リブ−エックス ファーマシューティカルズ,インコーポレイテッド Macrocyclic compounds and methods of making and using them

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2473525A1 (en) * 1980-01-11 1981-07-17 Roussel Uclaf NOVEL OXIMES DERIVED FROM ERYTHROMYCIN, PROCESS FOR PREPARING THEM AND THEIR APPLICATION AS MEDICAMENTS
GB8521402D0 (en) 1985-08-28 1985-10-02 Beecham Group Plc Chemical compounds
US4740502A (en) * 1986-06-20 1988-04-26 Abbott Laboratories Semisynthetic erythromycin antibiotics
DK90788A (en) 1987-02-24 1988-08-25 Beecham Group Plc erythromycin
US5302705A (en) * 1989-10-07 1994-04-12 Taisho Pharmaceutical Co., Ltd. 6-O-methylerythromycin a oxime derivatives
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
HU220631B1 (en) 2002-03-28
FI972493A0 (en) 1997-06-12
GEP20012391B (en) 2001-03-25
IT1276901B1 (en) 1997-11-03
MD1788F2 (en) 2001-11-30
MD1788G2 (en) 2002-05-31
NZ297446A (en) 1999-06-29
AU690791B2 (en) 1998-04-30
EE03401B1 (en) 2001-04-16
FI972493A (en) 1997-06-12
DE69515694D1 (en) 2000-04-20
ITMI942496A0 (en) 1994-12-13
HUT77126A (en) 1998-03-02
US5847092A (en) 1998-12-08
EE9700124A (en) 1997-12-15
LT4276B (en) 1998-01-26
EP0797579B1 (en) 2000-03-15
PT797579E (en) 2000-08-31
ES2144154T3 (en) 2000-06-01
TJ306B (en) 2001-08-06
MD970243A (en) 1999-05-31
SI9520124A (en) 1998-04-30
JPH10510520A (en) 1998-10-13
CZ289943B6 (en) 2002-04-17
CN1169727A (en) 1998-01-07
GR3033622T3 (en) 2000-10-31
RO116282B1 (en) 2000-12-29
OA10491A (en) 2002-04-10
LV11898A (en) 1997-12-20
RU2152951C1 (en) 2000-07-20
KR100367559B1 (en) 2003-04-21
BR9510015A (en) 1997-10-28
PL182053B1 (en) 2001-10-31
BG101570A (en) 1998-02-27
CA2207029A1 (en) 1996-06-20
WO1996018633A1 (en) 1996-06-20
AP9700989A0 (en) 1997-07-31
CN1046535C (en) 1999-11-17
PL320688A1 (en) 1997-10-27
ITMI942496A1 (en) 1996-06-13
UA48958C2 (en) 2002-09-16
LV11898B (en) 1998-03-20
NO972702L (en) 1997-08-13
CZ178697A3 (en) 1997-12-17
DK0797579T3 (en) 2000-06-05
ATE190620T1 (en) 2000-04-15
NO972702D0 (en) 1997-06-12
MX9704253A (en) 1997-09-30
DE69515694T2 (en) 2000-10-26
NO309816B1 (en) 2001-04-02
AU4260396A (en) 1996-07-03
BG63261B1 (en) 2001-07-31
EP0797579A1 (en) 1997-10-01
AP739A (en) 1999-03-24

Similar Documents

Publication Publication Date Title
IL132767A0 (en) 9-Oxime erythromycin derivatives
HUP0001330A3 (en) 3'-n-oxide, 3'-n-dimethylamine, 9-oxime erythromycin a derivatives
IL129946A0 (en) Erythromycin a derivatives
AP9700989A0 (en) Erythromycin a 9-0-oxime derivatives endowed with antibiotic activity
ZA989835B (en) Erythromycin a derivatives
ZA989830B (en) Erythromycin a derivatives
AU6421398A (en) Erythromycin a derivatives
AU9646098A (en) Erythromycin a derivatives
AU5376394A (en) Erythromycin derivative
ZA981572B (en) Erythromycin a derivatives
IL115312A0 (en) Antibiotic macrolides
AU4222797A (en) Erythromycin a derivatives
AU4472797A (en) Erythromycin a derivatives
AU4472697A (en) Erythromycin a derivatives
EP0459525A3 (en) Genes encoding a 3-acylation enzyme for macrolide antibiotics
IL99288A0 (en) Antibiotic ge1655 complex and its factors a,b and c
SI1100806T1 (en) Erythromycin derivative with antibiotic activity
AU9645998A (en) Erythromycin a derivatives
IL115996A0 (en) Fluorenyl-hydroxamic derivatives endowed with immunosuppresive and anti-inflammatory activity
ZA951845B (en) Acid-stabile erythromycin derivatives
SI0966477T1 (en) 3'-n-oxide, 3'-n-dimethylamine, 9-oxime erythromycin a derivatives

Legal Events

Date Code Title Description
MM9A Lapsed patents

Effective date: 20051207